Darunavir 600mg tabs/PAC-60

Darunavir 600mg tablets, bottle pack of 60
Indicative Price : Upon Request

NOTE: The description below is for a standard product. It is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: supply@unicef.org

General Description:
Darunavir 600mg tablets, bottle pack of 60

Technical Specifications:
Each film coated tablet contains Darunavir Ethanolate, equivalent to 600mg Darunavir.
Note: tablets must be administered in combination with Ritonavir 100mg as a booster.

Therapeutic class:
Protease Inhibitor (PI)

Standard shelf life:
24 months

Other available formulations:
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use:
For more details, please click the links listed below:

WHO treatment guidelines


WHO Essential Medicines Library

or your regional national guidelines

For details about paediatric dosage schemes, please click the links listed below:


WHO Generic tool for assessing paediatric ARV dosing

Management of HIV-1 infection in infected adults and children above 6 years of age in combination with 100mg Ritonavir as a booster to Darunavir and in combination with at least two other antiretroviral drugs.
Administration: per mouth (PO)

Do not store above 30ºC
Store in tightly closed original container.
Keep out of reach and sight of children.

Dispensing instructions
Dispense in original container. Do not repack

Regulatory Status:
For latest updates, please click the links listed below:

List of WHO Prequalified Medicines

List of USFDA approved and tentatively approved items

Related Products